Similar articles for PMID: 19777192

Year	Number of Results
1991	2
1994	2
1995	4
1997	1
1998	1
1999	1
2001	2
2002	4
2003	4
2004	1
2005	2
2006	4
2007	2
2008	1
2009	7
2010	5
2011	7
2012	9
2013	11
2014	7
2015	6
2016	6
2017	2
2018	5
2019	5
2020	6
2021	8
2022	7
2023	1
2024	0

1

Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy.

Ripley RT, Davis JL, Klapper JA, Mathur A, Kammula U, Royal RE, Yang JC, Sherry RM, Hughes MS, Libutti SK, White DE, Steinberg SM, Dudley ME, Rosenberg SA, Avital I. Ripley RT, et al. Ann Surg Oncol. 2010 Jan;17(1):163-70. doi: 10.1245/s10434-009-0677-0. Epub 2009 Sep 24. Ann Surg Oncol. 2010. PMID: 19777192 Free PMC article.

2

Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma.

Alvarez-Downing MM, Inchauste SM, Dudley ME, White DE, Wunderlich JR, Rosenberg SA, Kammula US. Alvarez-Downing MM, et al. World J Surg Oncol. 2012 Jun 22;10:113. doi: 10.1186/1477-7819-10-113. World J Surg Oncol. 2012. PMID: 22726267 Free PMC article.

3

Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.

Saberian C, Amaria RN, Najjar AM, Radvanyi LG, Haymaker CL, Forget MA, Bassett RL, Faria SC, Glitza IC, Alvarez E, Parshottam S, Prieto V, Lizée G, Wong MK, McQuade JL, Diab A, Yee C, Tawbi HA, Patel S, Shpall EJ, Davies MA, Hwu P, Bernatchez C. Saberian C, et al. J Immunother Cancer. 2021 May;9(5):e002449. doi: 10.1136/jitc-2021-002449. J Immunother Cancer. 2021. PMID: 34021033 Free PMC article. Clinical Trial.

4

Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial.

Khammari A, Nguyen JM, Leccia MT, Guillot B, Saiagh S, Pandolfino MC, Knol AC, Quéreux G, Chiffolettau A, Labarrière N, Dréno B. Khammari A, et al. Cancer Immunol Immunother. 2020 Aug;69(8):1663-1672. doi: 10.1007/s00262-020-02572-1. Epub 2020 Apr 18. Cancer Immunol Immunother. 2020. PMID: 32306076 Clinical Trial.

5

Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases.

Mehta GU, Malekzadeh P, Shelton T, White DE, Butman JA, Yang JC, Kammula US, Goff SL, Rosenberg SA, Sherry RM. Mehta GU, et al. J Immunother. 2018 Jun;41(5):241-247. doi: 10.1097/CJI.0000000000000223. J Immunother. 2018. PMID: 29672342 Free PMC article.

6

Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes.

Friedman KM, Prieto PA, Devillier LE, Gross CA, Yang JC, Wunderlich JR, Rosenberg SA, Dudley ME. Friedman KM, et al. J Immunother. 2012 Jun;35(5):400-8. doi: 10.1097/CJI.0b013e31825898c5. J Immunother. 2012. PMID: 22576345 Free PMC article.

7

Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients.

Ridolfi R, Flamini E, Riccobon A, De Paola F, Maltoni R, Gardini A, Ridolfi L, Medri L, Poletti G, Amadori D. Ridolfi R, et al. Cancer Immunol Immunother. 1998 Jun;46(4):185-93. doi: 10.1007/s002620050477. Cancer Immunol Immunother. 1998. PMID: 9671141

8

Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma.

Ridolfi L, Ridolfi R, Riccobon A, De Paola F, Petrini M, Stefanelli M, Flamini E, Ravaioli A, Verdecchia GM, Trevisan G, Amadori D. Ridolfi L, et al. J Immunother. 2003 Mar-Apr;26(2):156-62. doi: 10.1097/00002371-200303000-00008. J Immunother. 2003. PMID: 12616107

9

Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience.

Rose DM, Essner R, Hughes TM, Tang PC, Bilchik A, Wanek LA, Thompson JF, Morton DL. Rose DM, et al. Arch Surg. 2001 Aug;136(8):950-5. doi: 10.1001/archsurg.136.8.950. Arch Surg. 2001. PMID: 11485537

10

[Adjuvant adoptive immunotherapy in patients with stage III and resected stage IV melanoma: a pilot study].

Verdecchia GM, Ridolfi L, Ridolfi R, Riccobon A, Bertagni A, Vagliasindi A, Petrini M, Stefanelli M, Milandri C, Amadori D. Verdecchia GM, et al. Tumori. 2003 Jul-Aug;89(4 Suppl):298-300. Tumori. 2003. PMID: 12903626 Clinical Trial. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year